Home › Gilead profits continue to rise on strength of HIV drugs
 

Keywords :   


Gilead profits continue to rise on strength of HIV drugs

2013-02-05 05:42:42| Biotech - Topix.net

Gilead Sciences on Monday reported higher-than-expected quarterly profit and revenue as sales of the Foster City company's flagship HIV drugs exceeded Wall Street estimates.

Tags: continue rise strength drugs

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
10.10Eastern North Pacific Tropical Weather Outlook
10.10Hurricane Milton Graphics
10.10BASF Completes Capability Upgrades for Superabsorbent Polymers in North America
10.10BASF Completes Capability Upgrades for SAP in North America
10.10Trash Fairies Selected as Preferred National Vendor for Gallery Residential
10.10Are UK Businesses Ready for a Circular Economy Revolution?
10.10Hurricane Milton Potential Storm Surge Flooding Map
10.10Tecnocut opens office in Italy
More »